effect of cost-sharing on the utilization of prescription drugs for chronically ill patients
Read Online
Share

effect of cost-sharing on the utilization of prescription drugs for chronically ill patients

  • 574 Want to read
  • ·
  • 65 Currently reading

Published by RAND Corp. in Santa Monica, CA .
Written in English

Subjects:

  • Drug utilization -- United States,
  • Drugs -- Purchasing -- United States,
  • Prescription pricing -- United States,
  • Older people -- Drug use -- United States -- Costs,
  • Patient compliance -- United States

Book details:

Edition Notes

StatementMatthew D. Solomon
SeriesDissertation / Pardee Rand Graduate School -- RGSD-193, Dissertation (Pardee Rand Graduate School) -- RGSD-193
ContributionsPardee Rand Graduate School, Rand Corporation
The Physical Object
Paginationxii, 135 p. :
Number of Pages135
ID Numbers
Open LibraryOL15572915M

Download effect of cost-sharing on the utilization of prescription drugs for chronically ill patients

PDF EPUB FB2 MOBI RTF

  Medications are a crucial component of the therapeutic regimen for the chronically ill, 7 and the interruption of drug therapy can have negative health consequences, 8,9 particularly for the elderly, who have the highest rates of chronic disease and prescription drug use. 12–15 Studies measuring the effect of pharmacy benefits designs on drug Cited by: The effects of prescription drug cost sharing: A review of the evidence for chronically ill patients. At times, higher levels of cost sharing can affect the use of essential medications and. Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill Article in Archives of internal medicine (8); discussion April with 26 Reads How we measure 'reads'. The Effect of Cost-Sharing on the Utilization of Prescription Drugs for Chronically Ill Patients Matthew D. Solomon This document was submitted as a dissertation in September in partial fulfillment of the requirements of the doctoral degree in public policy analysis at the Pardee RAND Graduate School. The faculty committee that supervised.

  Despite the market trends in increasing patient out-of-pocket (OOP) costs for specialty drugs, the impact of patient cost sharing on specialty drug utilization and outcomes is . Results: Higher levels of prescription drug cost sharing generally produce intended effects, namely, decreasing the consumption of prescription . Many chronically ill patients take less of their medication than has been prescribed, owing to cost concerns, especially those patients with low incomes, multiple chronic health problems, or no prescription drug coverage.1– 3 The consequences of cost-related medication underuse include increased emergency department visits, psychiatric admissions, and nursing home Cited by: More generic prescription drugs are being placed on higher formulary tiers, meaning patients have a higher cost-sharing for these drugs, the Avalere analysis revealed. Fifty-three percent fewer generic drugs were placed on the lowest tier – which yielded the lowest cost-sharing – between and

  Context Many health plans have instituted more cost sharing to discourage use of more expensive pharmaceuticals and to reduce drug spending.. Objective To determine how changes in cost sharing affect use of the most commonly used drug classes among the privately insured and the chronically ill.. Design, Setting, and Participants Retrospective US study Cited by: Introduction The problem with medication costs. The costs of prescription drugs pose a growing burden to health care payers and patients (Gabel et al., ).In the United States, the average number of prescriptions per person more than doubled between and (Schur, Doty, & Berk, ). $ billion dollars were spent on prescription drugs in (a 15% increase Cited by: By contrast, the switch by Employer 2 from a two-tier to a three-tier formulary with no increases in cost sharing for drugs in tiers 1 and 2 had little effect on the probability of the use of a Cited by: The evidence clearly suggests that patients are responsive to the cost-sharing arrangements in prescription drug plans, even among the chronically ill. Benefit caps act in a manner consistent with other cost-sharing features; however, little is known about the dynamics of these by: